GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kaleido Biosciences KLDO · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Kaleido Biosciences — daily KLDO Delayed
Market value
$4,262
Last close × shares
Volume
4k
Shares, 9 Nov 2026

About Kaleido Biosciences

Its shares trade under the ticker KLDO. It has been listed since 28 February 2019. In the fiscal year to 31 December 2021, it reported revenue of $1.1m and a net loss of $90.3m. At that date it held total assets of $50.1m and shareholders' equity of $10.6m.

Kaleido Biosciences, Inc. engages in the provision of healthcare services. The company is headquartered in Bedford, Massachusetts. The company went IPO on 2019-02-28. The Company’s product candidates are Microbiome Metabolic Therapies (MMTs), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ’s existing microbes. Its proprietary product platform includes ex vivo screening of microbiome samples from healthy volunteers, ex vivo testing of patient microbiome samples and advancement of its MMT candidates into non- Investigational New Drug Application (IND) human clinical studies. Its ex vivo screening process combines advances in drug discovery with microbiome science.

Figures and description from our data supplier, not checked against the company's own report.

More about Kaleido Biosciences →

Latest on Kaleido Biosciences

Our reporting

We have not reported on Kaleido Biosciences yet.

Next results

3 Mar 2027

Due on 3 Mar 2027. Analysts expect earnings of -0.58 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Kaleido Biosciences's ticker?

Kaleido Biosciences trades as KLDO on its US listing, under ISIN US4833471000.

What was Kaleido Biosciences's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

When does Kaleido Biosciences next report results?

Results are expected on 3 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.